Human Papilloma virus type 16 E7 antibody

An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma. Carper MB et al., 2019 Nov 5, Cell Rep

Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region. Zheng Y et al., 2020 Sep 29, J Virol

Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region. Zheng Y et al., 2020 Sep 29, J Virol

HIV-1 Protease Inhibitors Slow HPV16-Driven Cell Proliferation through Targeted Depletion of Viral E6 and E7 Oncoproteins. Park S et al., 2021 Feb 24, Cancers (Basel)

Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes. Lo Cigno I et al., 2020 Jan 31, J Virol

Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus. Zhao J et al., 2019 May 24, Nat Commun